FDA Scraps Suffixes for Older Biologics’ Proper Names

Drug Industry Daily
A A
The FDA has decided not to require four-letter suffixes for already-approved or licensed biological products with no FDA-designated suffix in their proper names.

To View This Article:

Login

Subscribe To Drug Industry Daily